Cases 91 - 100 of 276
Bausch Health Ireland Limited et al v. Lupin Ltd. et al
as 1:2019cv00626
Plaintiff:
Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. and Norgine B.V.
Defendant:
Lupin Ltd., Lupin Inc., Lupin Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH IRELAND LIMITED et al v. LUPIN LTD. et al
as 1:2019cv09178
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. and NORGINE B.V.
Defendant:
LUPIN LTD., LUPIN INC., LUPIN PHARMACEUTICALS, INC. and others
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH IRELAND LIMITED et al v. LUPIN LTD. et al
as 3:2019cv09178
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. and NORGINE B.V.
Defendant:
LUPIN LTD., LUPIN INC., LUPIN PHARMACEUTICALS, INC. and others
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. LUPIN LIMITED et al
as 3:2019cv07165
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
LUPIN LIMITED and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 28 U.S.C. § 1338
Merck Sharp & Dohme Corp. v. Lupin Limited et al
as 1:2019cv00347
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. v. Lupin Ltd. et al.
as 1:2019cv00110
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. v. Lupin Ltd. et al.
as 1:2019cv00109
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. LUPIN LTD. et al
as 3:2018cv17501
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant:
LUPIN LTD. and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al
as 1:2018cv01690
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
